PRDM16 and acute kidney injury: Additionally, we found that formononetin, a small molecule compound, ameliorated the progression of I/R‐ and cisplatin‐triggered AKI by regulating the PRDM16/S100A6/PKC‐η/ROS/p38MAPK and JNK axes.